Literature DB >> 30196510

Measuring Antibody-Antigen Binding Kinetics Using Surface Plasmon Resonance.

Stephen Hearty1,2, Paul Leonard1,2, Hui Ma1, Richard O'Kennedy3,4,5.   

Abstract

Surface plasmon resonance (SPR) is now widely embraced as a technology for monitoring a diverse range of protein-protein interactions and is considered almost de rigueur for characterizing antibody-antigen interactions. The technique obviates the need to label either of the interacting species, and the binding event is visualized in real time. Thus, it is ideally suited for screening crude, unpurified antibody samples that dominate early candidate panels following antibody selection campaigns. SPR returns not only concentration and affinity data but when used correctly can resolve the discrete component kinetic parameters (association and dissociation rate constants) of the affinity interaction. Herein, we outline some SPR-based generic antibody screening configurations and methodologies in the context of expediting data-rich ranking of candidate antibody panels and ensuring that antibodies with the optimal kinetic binding characteristics are reliably identified.

Keywords:  Affinity; Antibody; Antigen; Association rate; Dissociation rate; Screening; Surface plasmon resonance (SPR)

Mesh:

Substances:

Year:  2018        PMID: 30196510     DOI: 10.1007/978-1-4939-8648-4_22

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  Direct-MS analysis of antibody-antigen complexes.

Authors:  Shay Vimer; Gili Ben-Nissan; Michael Marty; Sarel J Fleishman; Michal Sharon
Journal:  Proteomics       Date:  2021-08-09       Impact factor: 3.984

Review 2.  Applications of Surface Plasmon Resonance and Biolayer Interferometry for Virus-Ligand Binding.

Authors:  Shruthi Murali; Richard R Rustandi; Xiwei Zheng; Anne Payne; Liang Shang
Journal:  Viruses       Date:  2022-03-29       Impact factor: 5.818

Review 3.  Role of Nano-miRNAs in Diagnostics and Therapeutics.

Authors:  Donatella Coradduzza; Emanuela Bellu; Antonella Congiargiu; Aleksei Pashchenko; Evzen Amler; Alois Necas; Ciriaco Carru; Serenella Medici; Margherita Maioli
Journal:  Int J Mol Sci       Date:  2022-06-20       Impact factor: 6.208

4.  In Silico Maturation of a Nanomolar Antibody against the Human CXCR2.

Authors:  Damiano Buratto; Yue Wan; Xiaojie Shi; Guang Yang; Francesco Zonta
Journal:  Biomolecules       Date:  2022-09-13

Review 5.  Structural and Biophysical Characterization of the HCV E1E2 Heterodimer for Vaccine Development.

Authors:  Eric A Toth; Andrezza Chagas; Brian G Pierce; Thomas R Fuerst
Journal:  Viruses       Date:  2021-05-29       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.